Lennart Brewitz

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Mathew Coleman

Professor

University of Birmingham

UNITED KINGDOM

View details

Takayuki Katoh

Associate Professor

University of Tokyo

JAPAN

View details

Giorgia Fiorini

Paul Scherrer Institut

SWITZERLAND

View details

Soran Mohammed

University of Southampton

UNITED KINGDOM

View details

Patrick Rabe

University of Oxford

UNITED KINGDOM

View details

BEN MARSHALL

Consultant in respiratory medicine and Honorary Associate Professor

University Hospital Southampton NHS Foundation Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lennart Brewitz

Research Interests

Explore related searches

Contact this professor

Articles (10)

5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5

In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5

Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis

Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease

Collaborators (6)

Mathew Coleman

Takayuki Katoh

Giorgia Fiorini

Soran Mohammed

Patrick Rabe

BEN MARSHALL

Make your next move.